Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
The Hidden Risks of QAC Disinfectants in Healthcare Facilities
Sprinkler Compliance: Navigating Code Mandates, Renovation Triggers and Patient Safety
Baptist Health Acquires South Arkansas Regional Hospital
Wider View: Planning LED Upgrades Across a Healthcare Portfolio
Cone Health Plans Hospital in Forsyth County of North Carolina